Time New York: Wed 17 Oct 18:10 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

AtriCure (ATRC) Looks Good: Stock Adds 6.8% in Session

Zacks

AtriCure, Inc. ATRC was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $30.93 –$35.58 in the past one-month time frame, witnessed a sharp increase on Friday.

The move came after the company announced pricing of public offering of its common stock.

The company has seen no changes when it comes to estimate revision over the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AtriCure currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.


Another stock worth considering in the Medical sector is Surmodics, Inc. SRDX which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ATRC going up? Or down? Predict to see what others think:Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.